These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 759070)

  • 21. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
    Gunawardhana L; Barr J; Weir AJ; Brendel K; Sipes IG
    Drug Metab Dispos; 1991; 19(3):648-54. PubMed ID: 1680632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of food deprivation on the rate of sulfamethazine elimination in goats.
    Abdullah AS; Baggot JD
    Vet Res Commun; 1988; 12(6):441-6. PubMed ID: 3222919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic studies on drug disposition in rabbits. II. Dose dependent pharmacokinetics of sulfamethizole.
    Katayama K; Ohtani H; Murai A; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1990 Feb; 13(2):108-19. PubMed ID: 2384847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfamethazine as a model compound to assess sex hormone-dependent cytochrome P-450 activity in rats.
    Witkamp RF; Nijmeijer SM; Yun H; Noordhoek J; van Miert AS
    Drug Metab Dispos; 1993; 21(3):441-6. PubMed ID: 8100499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion kinetics of 14C-sulfamethazine [4-amino-N-(4, 6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] metabolism in swine.
    Mitchell AD; Paulson GD
    Drug Metab Dispos; 1986; 14(2):161-5. PubMed ID: 2870889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
    Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylation phenotype in hypertensive patients.
    Huang CY; Chu JY; Yen TC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jan; 8(1):1-5. PubMed ID: 1548734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients.
    Schaaf LJ; Dobbs BR; Edwards IR; Perrier DG
    Eur J Clin Pharmacol; 1987; 32(4):411-8. PubMed ID: 3609119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylation of the heterocyclic amine batracylin by human liver.
    Stevens GJ; Payton M; Sim E; McQueen CA
    Drug Metab Dispos; 1999 Sep; 27(9):966-71. PubMed ID: 10460792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of sulfonamides in food-producing animals: pharmacokinetics of sulfamethazine in lambs.
    Bourne DW; Bevill RF; Sharma RJ; Gural RP; Dittert LW
    Am J Vet Res; 1977 Jul; 38(7):967-72. PubMed ID: 883724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
    Ylitalo P; Hinkka H
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of sulfonamides in food-producing animals IV: Pharmacokinetics of sulfamethazine in cattle following administration of an intravenous dose and three oral dosage forms.
    Bevill RF; Dittert LW; Bourne DW
    J Pharm Sci; 1977 May; 66(5):619-23. PubMed ID: 874742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of intravenous propylthiouracil.
    Giles HG; Roberts EA; Orrego H; Sellers EM
    J Clin Pharmacol; 1981; 21(11):466-71. PubMed ID: 7334138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dipyridamol kinetics.
    Mahony C; Wolfram KM; Cocchetto DM; Bjornsson TD
    Clin Pharmacol Ther; 1982 Mar; 31(3):330-8. PubMed ID: 7060316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, safety and tissue residues of sustained-release sulfamethazine in sheep.
    Bulgin MS; Lane VM; Archer TE; Baggot JD; Craigmill AL
    J Vet Pharmacol Ther; 1991 Mar; 14(1):36-45. PubMed ID: 2038093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
    Balakrishnan S; Ramu G
    Lepr India; 1977 Jan; 49(1):59-64. PubMed ID: 330945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of double genetic polymorphism on response to sulfamethazine.
    Woolhouse NM; Atu-Taylor LC
    Clin Pharmacol Ther; 1982 Mar; 31(3):377-83. PubMed ID: 7060320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo and in vitro effect of sulfamethazine on hepatic mixed function oxidases in rats.
    Kodam KM; Govindwar SP
    Vet Hum Toxicol; 1997 Jun; 39(3):141-6. PubMed ID: 9167242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.